ArticleDiabetes technology & therapeutics2016

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.

Roberto Visentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.